ACNE VULGARIS
Clinical trials for ACNE VULGARIS explained in plain language.
Never miss a new study
Get alerted when new ACNE VULGARIS trials appear
Sign up with your email to follow new studies for ACNE VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New acne combo shows promise in small study
Symptom relief CompletedThis study tested a combination of two topical medications—Winlevi and adapalene 0.3% gel—for treating acne vulgaris. Twenty participants aged 12 and older used the combo for 16 weeks. The goal was to see how many achieved clear or almost clear skin and to measure reductions in a…
Matched conditions: ACNE VULGARIS
Phase: PHASE4 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC
-
Generic acne gel goes head-to-head with brand-name Retin-A micro in large study
Symptom relief CompletedThis study tested whether a generic version of tretinoin gel works as well as the brand-name Retin-A Micro for treating acne. Over 1,000 people aged 12 to 40 with mild to moderate acne took part. The goal was to see if the generic gel is equally safe and effective at reducing pim…
Matched conditions: ACNE VULGARIS
Phase: PHASE1 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC
-
Ear massage boosts acne cream's power, study finds
Symptom relief CompletedThis study tested whether adding a non-invasive ear acupressure technique to a standard acne cream (adapalene) works better than the cream alone. Sixty-four people with mild to moderate acne took part. The goal was to see if the combination reduced acne severity and pimple counts…
Matched conditions: ACNE VULGARIS
Phase: NA • Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC
-
New acne gel shows promise in Head-to-Head trial
Symptom relief CompletedThis study tested a new gel called IDP-126 against a standard acne treatment (Epiduo® Forte) and a placebo gel. About 686 people with moderate to severe facial acne used one of the treatments daily for 12 weeks. The goal was to see which gel worked better at reducing pimples and …
Matched conditions: ACNE VULGARIS
Phase: PHASE2 • Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Apr 30, 2026 15:50 UTC
-
Probiotics may tame acne inflammation, small study finds
Symptom relief CompletedThis study looked at whether taking probiotics can reduce a protein in the blood (LRG1) that is linked to acne inflammation. Fifty adults with mild to moderate acne took probiotics, and researchers measured changes in their acne severity and satisfaction. The goal was to see if i…
Matched conditions: ACNE VULGARIS
Sponsor: Benha University • Aim: Symptom relief
Last updated Apr 30, 2026 15:49 UTC
-
New acne cream shows promise in early safety trial
Symptom relief CompletedThis early-stage study tested a new topical cream (PF-07905428) for acne in 52 healthy volunteers and people with moderate to severe acne. The main goal was to check safety and how the body processes the drug. Participants applied the cream daily for 2 to 4 weeks and were monitor…
Matched conditions: ACNE VULGARIS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Apr 30, 2026 15:48 UTC